LOGIN  |  REGISTER
Viking Therapeutics

Recent Insider Transactions - Dyne Therapeutics (NASDAQ: DYN)

Follow NASDAQ:DYN Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ DYN Dyne Therapeutics
Lucera Erick / officer: Chief Financial Officer
03/31/2025
Buy
$10.46
214,500
$2.244M
214,500
NASDAQ DYN Dyne Therapeutics
Friedl-Naderer Johanna / officer: Chief Commercial Officer
03/13/2025
Sell
$12.12
143
$2K
96,057
NASDAQ DYN Dyne Therapeutics
Scalzo Richard William / officer: SVP, Head of Finance & Admin.
03/11/2025
Sell
$11.38
1,343
$15K
122,330
NASDAQ DYN Dyne Therapeutics
Beskrovnaya Oxana / officer: Chief Scientific Officer
03/11/2025
Sell
$11.38
2,153
$25K
195,840
NASDAQ DYN Dyne Therapeutics
Kerr Douglas / officer: Chief Medical Officer
03/05/2025
Sell
$11.83
1,343
$16K
94,157
NASDAQ DYN Dyne Therapeutics
Cox John / director, officer: CEO & President
03/05/2025
Sell
$11.83
4,061
$48K
146,239
NASDAQ DYN Dyne Therapeutics
Scalzo Richard William / officer: SVP, Head of Finance & Admin.
03/05/2025
Sell
$11.83
917
$11K
123,673
NASDAQ DYN Dyne Therapeutics
Beskrovnaya Oxana / officer: Chief Scientific Officer
03/05/2025
Sell
$11.83
1,094
$13K
197,993
NASDAQ DYN Dyne Therapeutics
Beskrovnaya Oxana / officer: Chief Scientific Officer
02/18/2025
Sell
$13.95
2,598
$36K
199,087
NASDAQ DYN Dyne Therapeutics
Scalzo Richard William / officer: SVP, Head of Finance & Admin.
02/18/2025
Sell
$13.95
2,488
$35K
124,590

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous